Pharmaceuticals in India

Date: June 30, 2017
Pages: 40
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PBD5912676AEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in India
Pharmaceuticals in India

SUMMARY

Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

SYNOPSIS

Essential resource for top-line data and analysis covering the India pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

KEY HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
  • The Indian pharmaceuticals market had total revenues of $29.4bn in 2016, representing a compound annual growth rate (CAGR) of 16.8% between 2012 and 2016.
  • The Indian market has for a long time appeared to be one of the key areas for pharmaceutical growth throughout the world, with reliable growth rates and substantial potential for development.
  • Sanofi and GSK have been particularly successful in producing public campaigns about the risks of delaying diabetes treatment and investing heavily in local infrastructure
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in India
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
REASONS TO BUY
  • What was the size of the India pharmaceuticals market by value in 2016?
  • What will be the size of the India pharmaceuticals market in 2021?
  • What factors are affecting the strength of competition in the India pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in India's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Aurobindo Pharma Limited
Lupin Limited
Dr. Reddy's Laboratories Limited
Sun Pharmaceutical Industries Ltd.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: India pharmaceuticals market value: $ billion, 2012–16
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: India pharmaceuticals market share: % share, by value, 2016
Table 4: India pharmaceuticals market value forecast: $ billion, 2016–21
Table 5: Aurobindo Pharma Limited: key facts
Table 6: Aurobindo Pharma Limited: key financials ($)
Table 7: Aurobindo Pharma Limited: key financials (Rs.)
Table 8: Aurobindo Pharma Limited: key financial ratios
Table 9: Lupin Limited: key facts
Table 10: Lupin Limited: key financials ($)
Table 11: Lupin Limited: key financials (Rs.)
Table 12: Lupin Limited: key financial ratios
Table 13: Dr. Reddy's Laboratories Limited: key facts
Table 14: Dr. Reddy's Laboratories Limited: key financials ($)
Table 15: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 16: Dr. Reddy's Laboratories Limited: key financial ratios
Table 17: Sun Pharmaceutical Industries Ltd.: key facts
Table 18: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 19: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 20: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 21: India size of population (million), 2012–16
Table 22: India gdp (constant 2005 prices, $ billion), 2012–16
Table 23: India gdp (current prices, $ billion), 2012–16
Table 24: India inflation, 2012–16
Table 25: India consumer price index (absolute), 2012–16
Table 26: India exchange rate, 2012–16

LIST OF FIGURES

Figure 1: India pharmaceuticals market value: $ billion, 2012–16
Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 3: India pharmaceuticals market share: % share, by value, 2016
Figure 4: India pharmaceuticals market value forecast: $ billion, 2016–21
Figure 5: Forces driving competition in the pharmaceuticals market in India, 2016
Figure 6: Drivers of buyer power in the pharmaceuticals market in India, 2016
Figure 7: Drivers of supplier power in the pharmaceuticals market in India, 2016
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2016
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2016
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in India, 2016
Figure 11: Aurobindo Pharma Limited: revenues & profitability
Figure 12: Aurobindo Pharma Limited: assets & liabilities
Figure 13: Lupin Limited: revenues & profitability
Figure 14: Lupin Limited: assets & liabilities
Figure 15: Dr. Reddy's Laboratories Limited: revenues & profitability
Figure 16: Dr. Reddy's Laboratories Limited: assets & liabilities
Figure 17: Sun Pharmaceutical Industries Ltd.: revenues & profitability
Figure 18: Sun Pharmaceutical Industries Ltd.: assets & liabilities

COMPANIES MENTIONED

Aurobindo Pharma Limited
Lupin Limited
Dr. Reddy's Laboratories Limited
Sun Pharmaceutical Industries Ltd.
Skip to top


OTC Pharmaceuticals in India US$ 350.00 Sep, 2016 · 39 pages
Pharmaceutical Manufacturers - India US$ 1,863.00 Aug, 2011
Pharmaceutical Markets in India US$ 1,295.00 Apr, 2009 · 96 pages

Ask Your Question

Pharmaceuticals in India
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: